Developed in consultation with general practitioners, Quit’s online training supports the development of knowledge and skills to confidently provide smoking cessation care. There are two modules.
Module 1: Smoking Cessation Brief Advice Training for General Practitioners
The ‘Smoking Cessation Brief Advice Training for General Practitioners’ is designed to support smoking cessation care in general practice. It will equip general practitioners with the skills, confidence and knowledge to provide smoking cessation brief advice to patients who smoke.
This education has been approved as a Lung Learning Quality-Assured Activity.
Duration: 60-90 minutes
Cost: Free
Learning outcomes:
- Describe the negative impact smoking has on physical and mental health, and social outcomes.
- Discuss the use of the three-step (Ask, Advise, Help) model of brief advice for smoking cessation in clinical practice.
- Explain how currently available smoking cessation pharmacotherapy options may be used effectively to reduce withdrawal symptoms and minimise side effects.
- Identify and manage common and clinically significant drug interactions associated with smoking and stopping smoking.
Module 2: Nicotine Vaping Products: Considerations for GPs
The 'Nicotine Vaping Products: Considerations for GPs' training provides information and evidence-based guidance to GPs on the practicalities of prescribing nicotine vaping products for smoking cessation in the new regulatory environment, including how to maximise benefit and minimise risk.
Duration: 60 minutes
Cost: Free
Learning outcomes:
- Explain the current legal and regulatory framework for nicotine vaping products in Australia
- Discuss the currently available evidence for the use of nicotine vaping products in smoking cessation, and the potential risks and benefits
- Outline the current RACGP recommendations for the clinical use of nicotine vaping products in primary care
- Describe the key factors to consider when prescribing nicotine vaping products for patients.
Last updated: 13 November 2024